10th Annual International Symposium on Melanoma and Other Cutaneous Malignancies Medical Crossfire
10th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® Medical Crossfire®
Saturday, October 18, 2014 • 8:30 AM – 10:00 AM
Audience arrival/check-in and breakfast 8:00 AM – 8:30 AM.
16986 Dallas Parkway (northbound side of parkway)
Dallas, TX 75248
This program being filmed in front of a live studio audience, will update participants on advances in the field, with a focus on the changing treatment landscape for metastatic melanoma, including both recently approved agents, such as the targeted drugs dabrafenib and trametinib, the BRAF inhibitor vemurafenib, as well as investigational agents, including immunotherapy agents that are available via clinical trials. In a roundtable discussion format, our panel of experts will discuss late-stage investigational agents, such as PD1 and PD-L1 inhibitors, and investigational indications for approved agents. Then they will debate where approved agents fit into current treatment paradigms, focusing on how to sequence the agents in the treatment armamentarium to provide the best possible benefit. Case scenarios presented during the panel discussion will highlight some of the important clinical questions faced in clinical practice. Lastly, the panel will spend time discussing treatment options for advanced basal cell carcinoma.
Who Should Attend
This educational activity is directed toward medical oncologists, fellows, surgical, radiation oncologists, who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of skin and other cutaneous malignancies will be invited to participate.